Stem Cells as Therapy for Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis of Preclinical Studies
Open Access
- 9 December 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 8
Abstract
Background: Necrotizing enterocolitis (NEC) is the most common life-threatening gastrointestinal condition among very and extremely preterm infants. Stem cell therapy has shown some promising protective effects in animal models of intestinal injury, including NEC, but no systematic review has yet evaluated the preclinical evidence of stem cell therapy for NEC prevention or treatment.Methods: PubMed and EMBASE databases were searched for studies using an animal model of NEC with stem cells or their products. The SYRCLE tool was used for the assessment of risk of bias. A random-effects model was used to pool odds ratios (ORs) and 95% confidence interval (CI).Results: We screened 953 studies, of which nine (eight rat and one mouse models) met the inclusion criteria. All animal models induced NEC by a combination of hypothermia, hypoxia, and formula feeding. Risk of bias was evaluated as unclear on most items for all studies included. Meta-analysis found that both mesenchymal and neural stem cells and stem cell-derived exosomes reduced the incidence of all NEC (OR 0.22, 95% CI 0.16–0.32, k = 16), grade 2 NEC (OR 0.41, 95% CI 0.24–0.70, k = 16), and grade 3–4 NEC (OR 0.28, 95% CI 0.19–0.42, k = 16). k represents the number of independent effect sizes included in each meta-analysis. The effect of the exosomes was similar to that of the stem cells. Stem cells and exosomes also improved 4-day survival (OR 2.89 95% CI 2.07–4.04, k = 9) and 7-day survival (OR 3.96 95% CI 2.39–6.55, k = 5) after experimental NEC. Meta-analysis also found that stem cells reduced other indicators of intestinal injury.Conclusion: The data from this meta-analysis suggest that both stem cells and stem cell-derived exosomes prevented NEC in rodent experimental models. However, unclear risk of bias and incomplete reporting underline that poor reporting standards are common and hamper the reliable interpretation of preclinical evidence for stem cell therapy for NEC.Keywords
Funding Information
- ZonMw
This publication has 66 references indexed in Scilit:
- Progress in Using Systematic Reviews of Animal Studies to Improve Translational ResearchPLOS Medicine, 2013
- Evaluation of Excess Significance Bias in Animal Studies of Neurological DiseasesPLOS Biology, 2013
- Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanismGut, 2013
- Fecal Microbiota in Premature Infants Prior to Necrotizing EnterocolitisPLOS ONE, 2011
- Necrotizing EnterocolitisNew England Journal of Medicine, 2011
- Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMedLaboratory Animals, 2010
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Can Animal Models of Disease Reliably Inform Human Studies?PLOS Medicine, 2010
- Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using AnimalsPLOS ONE, 2009
- The development of animal models for the study of necrotizing enterocolitisDisease Models & Mechanisms, 2008